| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Physiology and Pharmacology (T.L.S., D.G.) and Surgical Sciences (Y.L., A.V.C., J.R.Z.), Section for Integrative Physiology, Karolinska Institutet, SE-17177 Stockholm, Sweden; and Laboratoire de Physiopathologie de la Nutrition (M.G.), Universite Paris 7, 75251 Paris, France
Address all correspondence and requests for reprints to: Juleen R. Zierath, Ph.D., Professor of Physiology, Department of Surgical Sciences, Section for Integrative Physiology, Karolinska Institutet, von Eulers väg 4, II, SE-171 77 Stockholm, Sweden. E-mail: Juleen.Zierath{at}fyfa.ki.se.
We determined basal and insulin-stimulated responses on signaling intermediates in soleus skeletal muscle from male Wistar and diabetic Goto-Kakizaki (GK) rats. Rats were infused with glucose (5 or 20 mM) for 3 h, followed by a continuous infusion of saline or insulin (3 U/kg·h) for 20 min. Under euglycemic and hyperglycemic conditions, basal and insulin-stimulated action on phosphatidylinositol (PI) 3-kinase, protein kinase B/Akt, and ERK were reduced in GK rats, whereas insulin-stimulated protein kinase C (PKC)
activity was not altered. Interestingly, basal PKC
activity was increased under hyperglycemic conditions in GK and Wistar rats. This finding of increased PKC
activity was confirmed in vitro in isolated soleus muscle exposed to high extracellular glucose, and occurred concomitant with an increase in PI-dependent kinase 1 (PDK-1) activity. The glucose effects were not specific to PKC
, because an increase in phosphorylation of PKC
/ß and PKC
, but not PKC
, in isolated soleus muscle exposed to 25 mM glucose was observed. In conclusion, insulin signaling defects in diabetic GK rats are not corrected by an acute normalization of glycemia. Interestingly, acute hyperglycemia leads to a parallel increase in PDK-1, PKC
/ß, PKC
, and PKC
phosphorylation/activity via a PI 3-kinase-protein kinase B/Akt-independent mechanism. The long-term consequence of elevated PDK-1 and PKC phosphorylation/activity should be considered in the context of diabetes mellitus, as hyperglycemia is a clinical feature of this disease.
This article has been cited by other articles:
![]() |
A. A. Bulhak, C. Jung, C.-G. Ostenson, J. O. Lundberg, P.-O. Sjoquist, and J. Pernow PPAR-{alpha} activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H719 - H727. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Block, A. Eid, K. K. Griendling, D.-Y. Lee, Y. Wittrant, and Y. Gorin Nox4 NAD(P)H Oxidase Mediates Src-dependent Tyrosine Phosphorylation of PDK-1 in Response to Angiotensin II: ROLE IN MESANGIAL CELL HYPERTROPHY AND FIBRONECTIN EXPRESSION J. Biol. Chem., August 29, 2008; 283(35): 24061 - 24076. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Liberman, B. Plotkin, T. Tennenbaum, and H. Eldar-Finkelman Coordinated phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 and protein kinase C{beta}II in the diabetic fat tissue Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1169 - E1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Hoy, C. R. Bruce, A. Cederberg, N. Turner, D. E. James, G. J. Cooney, and E. W. Kraegen Glucose infusion causes insulin resistance in skeletal muscle of rats without changes in Akt and AS160 phosphorylation Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1358 - E1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tsang, D. J. Hausenloy, M. M. Mocanu, R. D. Carr, and D. M. Yellon Preconditioning the Diabetic Heart: The Importance of Akt Phosphorylation Diabetes, August 1, 2005; 54(8): 2360 - 2364. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bustamante, U. Hasler, O. Kotova, A. V. Chibalin, D. Mordasini, M. Rousselot, A. Vandewalle, P.-Y. Martin, and E. Feraille Insulin potentiates AVP-induced AQP2 expression in cultured renal collecting duct principal cells Am J Physiol Renal Physiol, February 1, 2005; 288(2): F334 - F344. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |